<?xml version="1.0" encoding="UTF-8" ?>
<?xml-stylesheet type="text/xsl" href="/xsl/rss2.xsl"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
    <channel>
        <title>Celgene Corporation et al v. MSN Laboratories Private Limited et al :: Justia Dockets &amp; Filings</title>
        <link>https://dockets.justia.com/docket/delaware/dedce/1:2023cv00699/82886</link>
        <atom:link href="https://dockets.justia.com/docket/delaware/dedce/1:2023cv00699/82886/feed" rel="self" type="application/rss+xml" />
        <pubDate>Thu, 12 Nov 2026 12:53:56 -0800</pubDate>
        <lastBuildDate>Thu, 12 Nov 2026 12:53:56 -0800</lastBuildDate>
        <generator>Justia Dockets &amp; Filings</generator>
        <copyright>Copyright 2026 Justia Inc</copyright>
        <description>Celgene Corporation et al v. MSN Laboratories Private Limited et al - Docket Entries - Showing 1 through 9</description>
                                    <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                Pro Hac Vice Attorney Amy K. Wigmore, Gerard A. Salvatore, Heather M. Petruzzi, Nora Q.E. Passamaneck, Andrew J. Danford, and Li-tsung A. Chen for Celgene Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mkr) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_22252909</guid>
                <pubDate>
            Fri, 25 Aug 2023 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                Pro Hac Vice Attorney David Mlaver for Celgene Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_22252910</guid>
                <pubDate>
            Fri, 25 Aug 2023 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 9]]>
                    </title>
                <description>
            <![CDATA[
                STIPULATION and [Proposed] Order to Consolidate and Modify Scheduling Order by Bristol-Myers Squibb Company, Celgene Corporation, Celgene International Sarl. (Attachments: #1 Exhibit A)(Farnan, Brian) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_22252908</guid>
                <pubDate>
            Thu, 24 Aug 2023 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 8]]>
                    </title>
                <description>
            <![CDATA[
                MOTION for Pro Hac Vice Appearance of Attorney Amy K. Wigmore, Heather M. Petruzzi, Andrew J. Danford, Nora Q.E. Passamaneck, David Mlaver, Gerard A. Salvatore, and Li-jsung Alyssa Chen - filed by Bristol-Myers Squibb Company, Celgene Corporation, Celgene International Sarl. (Farnan, Michael) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_22252906</guid>
                <pubDate>
            Wed, 23 Aug 2023 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED, re #8 MOTION for Pro Hac Vice Appearance of Attorney Amy K. Wigmore, Heather M. Petruzzi, Andrew J. Danford, Nora Q.E. Passamaneck, David Mlaver, Gerard A. Salvatore, and Li-jsung Alyssa Chen, filed by Celgene Corporation, Celgene International Sarl, Bristol-Myers Squibb Company. Signed by Judge Richard G. Andrews on 8/23/2023. (nms) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_22252907</guid>
                <pubDate>
            Wed, 23 Aug 2023 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 7]]>
                    </title>
                <description>
            <![CDATA[
                STIPULATION TO EXTEND TIME to answer, move, or otherwise respond to the Complaint to 8/28/2023 - filed by Bristol-Myers Squibb Company, Celgene Corporation, Celgene International Sarl. (Farnan, Michael) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_21911512</guid>
                <pubDate>
            Thu, 06 Jul 2023 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED, re #7 Stipulation and Proposed Order to Extend Time (*Reset Answer Deadlines: MSN Laboratories Private Limited answer due 8/28/2023; MSN Pharmaceuticals, Inc. answer due 8/28/2023). Signed by Judge Richard G. Andrews on 7/6/2023. (nms) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_21911513</guid>
                <pubDate>
            Thu, 06 Jul 2023 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_21911511</guid>
                <pubDate>
            Wed, 05 Jul 2023 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 6]]>
                    </title>
                <description>
            <![CDATA[
                Summons Issued as to MSN Laboratories Private Limited and MSN Pharmaceuticals, Inc. on 6/27/2023. (jdb) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_21566861</guid>
                <pubDate>
            Tue, 27 Jun 2023 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 5]]>
                    </title>
                <description>
            <![CDATA[
                Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Bristol-Myers Squibb Company and Corporate Parent Celgene Corporation for Celgene International Sarl; Corporate Parent Bristol-Myers Squibb Company for Celgene Corporation filed by Bristol-Myers Squibb Company, Celgene Corporation, Celgene International Sarl. (jdb) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_21566860</guid>
                <pubDate>
            Tue, 27 Jun 2023 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 4]]>
                    </title>
                <description>
            <![CDATA[
                Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,846,628 B2; 11,571,436 B2. (jdb) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_21566859</guid>
                <pubDate>
            Tue, 27 Jun 2023 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 3]]>
                    </title>
                <description>
            <![CDATA[
                Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 05/18/2023. Date of Expiration of Patent: 05/14/2029 and 06/03/2030.Thirty Month Stay Deadline: 11/18/2025. (jdb) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_21566858</guid>
                <pubDate>
            Tue, 27 Jun 2023 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 2]]>
                    </title>
                <description>
            <![CDATA[
                Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jdb) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_21566857</guid>
                <pubDate>
            Tue, 27 Jun 2023 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 1]]>
                    </title>
                <description>
            <![CDATA[
                COMPLAINT filed against MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc. (Filing fee $ 402, receipt number ADEDC-4167174) - filed by Celgene Corporation, Bristol-Myers Squibb Company, Celgene International Sarl. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Civil Cover Sheet)(jdb) Modified on 7/5/2023 (nms). 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_21566856</guid>
                <pubDate>
            Tue, 27 Jun 2023 00:00:00 -0700
        </pubDate>
    </item>
                </channel>
</rss>
